Complementary and Alternative Medicine (CAM) Use in Patients Undergoing Radiotherapy: Sex-specific Prevalence and Associations of Use Based on the S3 Guideline Complementary Medicine in Oncology Questionnaire
The high rate of CAM utility before radiotherapy, especially among females, and the use of uncertain methods, highlights the need for standardized questionnaires to identify potential interactions. This would help enhance patient safety through structured screening and counseling.
Authors
- Lukas Käsmann (ORCID: https://orcid.org/0000-0001-6260-5249)
- Ralph Mücke (ORCID: https://orcid.org/0000-0002-8986-6884)
- Montserrat Pazos (ORCID: https://orcid.org/0000-0002-9888-8452)
- Claus Belka (ORCID: https://orcid.org/0000-0002-1287-7825)
- Oliver Micke (ORCID: https://orcid.org/0000-0002-3812-9251)
- Josefine Rauch
- Judith Büntzel (ORCID: https://orcid.org/0000-0002-9531-7910)
- Jutta Hübner
- Robert Rennollet
- Ralph Gurtner
Institutions
- LMU Klinikum (DE)
- Nephrologisches Zentrum Goettingen (DE)
- Jena University Hospital (DE)
- Francis Hospital (DE)
- St. Franziskus Hospital (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- In Vivo
- Published
- 2025-08-28
- DOI
- https://doi.org/10.21873/invivo.14097
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00